Topical enviroxime against rhinovirus infection.
Enviroxime, an inhibitor of rhinovirus replication, was studied in a double-blind, placebo-controlled trial with 99 volunteers. The efficacy of a nasal-spray formulation of enviroxime was tested as pretreatment or as postchallenge treatment for rhinovirus type 4 infection. In the regimens used, drug...
שמור ב:
| הוצא לאור ב: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1982
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185710/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6297380/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.22.6.1004 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|